- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cervical Intraepithelial Neoplasia Grade 2/3 in Canada
Total 33 results
-
Saint Thomas Hospital, PanamaCompletedLSIL, Low-Grade Squamous Intraepithelial LesionsPanama
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)CompletedCervical Cancer | Precancerous ConditionCanada
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)WithdrawnCervical Cancer | Precancerous ConditionCanada
-
Sunnybrook Health Sciences CentreMerck Canada Inc.Active, not recruitingHSIL, High-Grade Squamous Intraepithelial Lesions | Adenocarcinoma in Situ | Early Cervical CancerCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCervical CancerUnited States, Canada
-
University of British ColumbiaBritish Columbia Cancer Agency; Women's Health Research Institute of British...CompletedUterine Cervical Dysplasia | Uterine Cervix CancerCanada
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)TerminatedCervical Cancer | Precancerous ConditionCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCervical CancerUnited States, Canada, Nigeria
-
McGill UniversityCompletedCervical Cancer | Intraepithelial NeoplasiaCanada
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR)CompletedCervical Intraepithelial NeoplasiaCanada, Brazil
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCervical Cancer | Precancerous ConditionUnited States, Canada
-
Inovio PharmaceuticalsCompletedCervical Intraepithelial NeoplasiaSouth Africa, United States, Korea, Republic of, Canada, Estonia, India, Georgia, Australia, Puerto Rico
-
British Columbia Cancer AgencyM.D. Anderson Cancer Center; National Cancer Institute (NCI); The University... and other collaboratorsCompletedCervical Cancer | Precancerous ConditionUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR); Terry Fox FoundationActive, not recruitingHigh Grade Cervical Intra-epithelial NeoplasiaCanada
-
Sunnybrook Health Sciences CentreCompleted
-
National Cancer Institute (NCI)Active, not recruitingDedifferentiated Chondrosarcoma | Central Chondrosarcoma, Grade 2 | Central Chondrosarcoma, Grade 3 | Metastatic Clear Cell Sarcoma of Soft Tissue | Metastatic Primary Central Chondrosarcoma | Unresectable Primary Central ChondrosarcomaUnited States, Canada
-
MeiraGTx, LLCRecruitingGrade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsUnited States, Canada
-
McMaster UniversityMerck Frosst Canada Ltd.; Public Health Agency of Canada (PHAC); Juravinski Cancer...UnknownCervical Intraepithelial Neoplasia | Human Papillomavirus InfectionCanada
-
Mount Sinai Hospital, CanadaLondon Health Sciences Centre; Royal Alexandra Hospital; Foothills Medical CentreNot yet recruitingIntraventricular Hemorrhage of Newborn Grade 2 | Intraventricular Hemorrhage of Newborn Grade 3 | Intraventricular Haemorrhage Grade IVCanada
-
Inovio PharmaceuticalsCompletedAnal NeoplasmUnited States, Canada
-
GlaxoSmithKlineCompletedCervical Intraepithelial Neoplasia | Papillomavirus InfectionTaiwan, Germany, Colombia, Honduras, Panama
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 GliomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsCanada
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States, Canada
-
Institut de Recherches Internationales ServierActive, not recruitingRecurrent Glioma | Grade 2 Glioma | Residual GliomaUnited States, Canada, Spain, Italy, United Kingdom, Switzerland, Israel, Japan, Netherlands, Germany, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma | Stage 1 Neuroblastoma | Stage 2 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerBelgium, United States, Poland, India, Taiwan, Thailand, Korea, Republic of, Czechia, Russian Federation, United Kingdom, Spain, Australia, Canada, Italy, Netherlands
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States, Canada